Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5872_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
28 Мб
Скачать
22 Chemistry and Biology of Beta-Lactams
https://t.me/med1917
FIGURE 1.28 Skeletal formula of oxacillin.
FIGURE 1.29 Skeletal formula of amoxicillin.
hematuria, agranulocytosis, eosinophilia, leukopenia, neutropenia, thrombocytopenia, hepatotoxicity, acute interstitial nephritis, and fever.
A broad spectrum of antibiotics are referred to as broad-spectrum antibiotics because they are effec­tive against a wide range of Gram-negative bacteria, such as E. coli and S. typhi, which penicillin does not have the ability to kill. An example of this would be the antibiotics amoxicillin and ampicillin. There is, however, a growing incidence of resistance among these organisms.
In the penicillin family of antibiotics, amoxicillin (Figur e 1.29) belongs to the aminopenicillin class, which is a subclass of penicillin antibiotics. Infectious diseases such as middle ear infections, strep throat infections, pneumonias, skin infections, odontogenic infections, and urinary tract infections can all be treated by taking this drug. In most cases, it is taken by mouth, but injections are less common. Nausea and rash are two of the most common adverse effects associated with this medication. Additionally, as a result of the combination of clavulanic acid and this drug, it appears to increase the risk of yeast infec­tions as well as diarrhea.
In 1958, the discovery of amoxicillin took place, and it was rst used in medicine in 1972.
113
114
In the United States, amoxil has been approved for medical use since 1974, and in the United Kingdom, it has been approved since 1977. It is on the list of essential medicines, which is maintained by the WHO. There are many reasons why this antibiotic is one of the most commonly prescribed to children.
115
As a generic medication, amoxicillin is available on the market. Approximately 15 million prescriptions were written for this medication in the United States in 2020, making it the 40th most commonly prescribed medication in the country.
Among the semisynthetic derivatives of penicillin known as amoxicillin, such as amino-p-hydroxy­benzyl penicillin, amoxicillin has a structure similar to ampicillin; however, it has a better absorption rate when taken by mouth, giving rise to higher concentrations in the blood and urine.2 It is easy for amoxicillin to diffuse into tissues and body uids due to its high solubility. A small amount of it will pass through the placenta and will be excreted in small quantities into the breastmilk. As soon as amoxicillin attaches to the cell wall of susceptible bacteria, it causes them to die. Furthermore, it is also a bactericidal compound that can kill bacteria. There is good evidence that this product is effective against strepto­cocci, pneumococci, enterococci, H. inuenzae, E. coli, P. mirabilis, N. meningitidis, N. gonorrhoeae, Shigella, C. trachomatis, Salmonella, B. burgdorferi, and H. pylori.
Among the penicillin family of antibiotics, ampicillin is a member of the aminopenicillin class. A variety of bacterial infections can be treated and prevented using this drug, such as respiratory tract
23Beta-Lactams
https://t.me/med1917
infections, urinary tract infections, meningitis, salmonellosis, and endocarditis, among others. A group B streptococcal infection may also be prevented in newborns with the use of this medication. The medi­cine can be taken by mouth, by injection into a muscle, or by intravenous administration. Among the most common side effects of this medication are rash, nausea, and diarrhea. In the case of people who are allergic to penicillin, the drug should not be used. Anaphylaxis and C. difcile colitis are examples of serious side effects that may occur.
In 1958, the ampicillin (Figure 1.30) antibiotic was discovered and was made commercially available
117
in 1961.
It is listed on the list of essential medicines of the WHO. According to the WHO, ampicillin is one of the most critical antibiotics for human medicine. There is a generic version of this medication available on the market.
Infections caused by many different types of bacteria, both Gram-positive and Gram-negative, can be treated with ampicillin. In addition to the fact that it was the rst penicillin with “broad spectrum” activity against Gram-positive bacteria, it was also effective against S. pneumoniae, S. pyogenes, some isolates of S. aureus (not penicillin-resistant or methicillin-resistant strains), Trueperella, and some Enterococcus strains. It is also one of the few antibiotics that work against multidrug-resistant E. faecalis and E. faecium.
118
This compound is effective against different strains of Gram-negative bacteria, includ­ing N. meningitidis, some strains of H. inuenzae, and some strains of Enterobacteriaceae (although most strains of Enterobacteriaceae and Pseudomonas are resistant).
119
This antibiotic’s spectrum of activity can be enhanced by co-administration of sulbactam, a drug that inhibits beta-lactamase, an enzyme produced by bacteria that is responsible for inactivating ampicillin and other related antibiotics.
120, 121
There are times when this antibiotic is used in conjunction with other antibiotics that have different mechanisms of action, such as vancomycin, linezolid, daptomycin, and tigecycline.
16, 122
In terms of its activity, it is roughly equivalent to that of amoxicillin. This antibiotic is capable of penetrating Gram-positive as well as some Gram-negative bacteria. It differs from penicillin G, or ben­zylpenicillin, only by the presence of an amino group, which makes it unique. The amino group present on both ampicillin and amoxicillin is what allows these antibiotics to pass through the pores of the outer membrane of Gram-negative bacteria, including E. coli, P. mirabilis, S. enterica, and Shigella.
123
The action of ampicillin can be described as an irreversible inhibitor of the enzyme transpeptidase, which is necessary for bacteria to make their cell walls in order to survive. As ampicillin inhibits the third and nal stages of bacterial cell wall synthesis in binary ssion, which ultimately leads to the lysis of bacteria, ampicillin is usually considered a bacteriolytic drug. There are a number of ampicillin precursors that are currently available on the market. In the gut, these compounds are broken down to release ampicillin, which acts as a drug. It is important to note that none of the following prodrugs of ampicillin are currently being used: pivampicillin, metampicillin, bacampicillin, hetacillin, talampicil­lin, and epicillin (F igure 1.31).
There is another class of antibiotics known as antipseudomonal antibiotics. Gram-negative bacteria, such as P. aeruginosa, are naturally resistant to a wide range of antibiotics. A number of efforts were made during the 1960s and 1970s in order to discover antibiotics that were active against Pseudomonas species. Within this group of antibiotics, there are two types: carboxypenicillins and ureidopenicillins. In all cases, the drugs are administered by injection: none of them can be taken orally. Carbenicillin, ticarcillin, and temocillin are some of the carboxypenicillins that are included in this group. There are three types of ureidopenicillins: mezlocillin, piperacillin, and azlocillin.
In 1970, scientists at Beecham discovered carbenicillin (Figu re 1.32) and marketed it under the name Pyopen.
124
It covers a wide range of Gram-negative bacteria, which includes P. aeruginosa, as well as a
FIGURE 1.30 Chemical structure of ampicillin.
24 Chemistry and Biology of Beta-Lactams
https://t.me/med1917
FIGURE 1.31 Chemical structures of pivampicillin, metampicillin, bacampicillin, hetacillin, talampicillin, and epicillin.
FIGURE 1.32 Structural diagram of carbenicillin.
limited range of Gram-positive bacteria. There is a tendency for carboxypenicillins to be degraded by beta-lactamase enzymes, although they are more resistant to degradation than ampicillin is to it. There is also evidence that carbenicillin is more stable at lower pH levels than ampicillin.
The substance in question is a semisynthetic analog of the naturally occurring benzylpenicillin. It is possible to experience bleeding when taking carbenicillin at high doses. In the distal convoluted tubules of the kidney, carbenicillin can cause hypokalemia by promoting potassium loss as a result of its use. Several studies have shown that carbenicillin is effective in the treatment of urinary tract infections caused by bacteria such as P. aeruginosa, E. coli, and some species of Proteus. Listed below is some information regarding the susceptibility data of a few medically signicant organisms to carbenicillin. It
25Beta-Lactams
https://t.me/med1917
is important to note that these are not all the species of bacteria that are susceptible to carbenicillin: E. coli 1.56– 64 μg/mL, P. mirabilis 1.56 –3.13 μg/mL, and P. aeruginosa 3.13–>1024 μg/mL.
Ticarcillin (Fig ure 1.33) is a carboxypenicillin that belongs to the group of antibiotics. It can be sold and used as ticarcillin/clavulanic acid when combined with clavulanate. This antibiotic is primarily used in the treatment of Gram-negative bacteria, particularly P. aeruginosa and P. vulgaris, which are the most common Gram-negative bacteria. In addition to that, it is one of the few antibiotics that are capable of treating infections caused by S. maltophilia. This product is available in two types of powder: white and pale yellow. It is a highly soluble compound in water, but it should only be dissolved immediately prior to use to prevent it from degrading. As far back as 1963, the invention was patented. In molecular biology, ticarcillin is commonly used to test the uptake of marker genes into bacteria instead of ampicil­lin, which is an antibiotic used to treat bacteria. In addition, it prevents the appearance of satellite colo­nies, which may occur in the medium if ampicillin is broken down. Molecular biology uses it as well to kill Agrobacterium, which is used to deliver genes into the cells of plants.
A beta-lactamase-resistant penicillin, temocillin (Figure 1.34), has been introduced by Beecham and is marketed by Eumedica Pharmaceuticals under the brand name Negaban.
125, 126
This drug is primarily used for treating multiple drug-resistant Gram-negative bacteria that are resistant to multiple types of antibiotics. The compound is a 6-methoxy penicillin; it is also a carboxypenicillin.
127
There are several
different organisms that it is normally effective against, including M. catarrhalis, B. abortus, B. cepacia,
C. species, E. coli, H. inuenzae, K. pneumoniae, P. multocida, P. mirabilis, S. typhimurium, and Y. enterocolitica. Furthermore, it has also been shown to be effective against some species of Enterobacter, M. morganii, and Serratia. In the case of Acinetobacter species or P. aeruginosa, temocillin does not
exhibit any useful activity. In general, its primary use is against Enterobacteriaceae, and in particular against strains that produce extended-spectrum beta-lactamases or AmpC beta-lactamases.
128
Mezlocillin (Figure 1.35) is a generally recognized penicillin antibiotic that has a wide spectrum of activity. The antibiotic is effective against both Gram-negative bacteria and some Gram-positive bac­teria. In contrast to most other extended-spectrum penicillins, it is excreted by the liver, making it an excellent choice for treating infections of the biliary tract, such as ascending cholangitis. In the same way as all other beta-lactam antibiotics, mezlocillin inhibits the third and last stages of the synthesis of the bacterial cell wall by binding to PBPs found on bacteria. Ultimately, this will result in the lysis of
FIGURE 1.33 Structural diagram of ticarcillin.
FIGURE 1.34 Chemical diagram for temocillin.
26 Chemistry and Biology of Beta-Lactams
https://t.me/med1917
FIGURE 1.35 Structural diagram of mezlocillin.
FIGURE 1.36 Skeletal formula of piperacillin.
the cells. It is possible to make mezlocillin in a variety of ways, including by reacting ampicillin with chlorocarbamate-1 in the presence of triethylamine.
Piperacillin (Figur e 1.36) belongs to the ureidopenicillin class of beta-lactam antibiotics. various types of infections that can be treated with piperacillin, such as abdominal infections, bactere­mia, gynecological infections, respiratory infections, and urinary infections, that are caused mostly by P. aeruginosa and other bacteria of infectious origin. ureidopenicillins is characterized by the incorporation of a polar side chain that enhances the penetration of the antibiotic into Gram-negative bacteria and reduces the susceptibility to cleavage by Gram-negative beta-lactamase enzymes. As a result of these properties, the product is able to inhibit the growth of the important hospital pathogen P. aeruginosa. As a result, piperacillin is sometimes referred to as an “antipseudomonal penicillin”.
Piperacillin, when used alone, is not very effective against Gram-positive pathogens, such as S. aureus, as the beta-lactam ring is hydrolyzed by the beta-lactamase of the bacteria. In 1974, the drug was patented, and it was approved for medical use in 1981. The most common way to use piperacillin is to combine it with the beta-lactamase inhibitor tazobactam (piperacillin/tazobactam), which will increase piperacillin’s effectiveness by inhibiting many of the beta-lactamases to which it is susceptible. As a result of the co-administration of tazobactam, there is no evidence that it confers activity against MRSA, as penicillin (and most other beta-lactams) do not avidly bind to the PBPs of this pathogen. to the WHO, piperacillin is one of the most critical compounds in human medicine. The most com­mon side effects associated with the administration of piperacillin–tazobactam include gastrointestinal
129
There are
130
The chemical structure of piperacillin and other
131
According
27Beta-Lactams
https://t.me/med1917
symptoms such as constipation, diarrhea, nausea, and vomiting; dermatologic symptoms such as ery­thema, pain, phlebitis, and rash; and neurologic symptoms such as headaches and insomnia.
132
Azlocillin (Figure 1.37) is an acyl ampicillin antibiotic with a broad spectrum of activity, as well as a higher permeation rate in vitro as compared to carboxy penicillin antibiotics. The properties of azlocillin are similar to those of mezlocillin and piperacillin. The antibiotic exhibits antibacterial activity against a wide range of bacteria, including P. aeruginosa, and, unlike most cephalosporins, it demonstrates antimicrobial activity against enterococci, in contrast to other antibiotics. Here is a look at some data regarding MIC susceptibility for a few medically signicant bacteria: E. coli 1–32 μg/mL, Haemophilus spp. 0.03–2 μg/mL, and P. aeruginosa 4–6.25 μg/mL.
1.3.2 Cephalosporins
A cephalosporin (Figu re 1.38) is a class of beta-lactam antibiotics that are derived from the fungus Acremonium, which was formerly known as Cephalosporium. As a group with cephamycins, they are considered to be a subgroup of beta-lactam antibiotics known as cephems. Cephalosporin was rst dis­covered in 1945, and its rst sales took place in 1964.16 There are six dihydrothiazine rings in a cephalo­sporin molecule. In general, substitutions at position 3 affect the pharmacology of the drug; substitutions at position 7 affect the antibacterial activity of the drug, but this is not always the case.
Cephalosporin antibiotics can be prescribed for the prophylaxis and treatment of infections caused by bacteria that are susceptible to this particular form of antibiotic. A majority of the rst-generation cephalosporins are active against Gram-positive bacteria, such as Staphylococcus and Streptococcus. Therefore, they are mostly used in the treatment of skin and soft tissue infections, as well as the preven­tion of hospital-acquired surgical infections.
133
Over time, successive generations of cephalosporins have increased their activity against Gram-negative bacteria, even though they have often reduced their activ­ity against Gram-positive organisms. Due to the different structure of the beta-lactam antibiotics, the antibiotic may be used in patients who are allergic to penicillin. It is possible for the drug to be excreted in the urine after it has been taken.
FIGURE 1.37 Skeletal formula of azlocillin.
FIGURE 1.38 Core structure of the cephalosporin antibiotics.
28 Chemistry and Biology of Beta-Lactams
https://t.me/med1917
Cephalosporin therapy is associated with a number of adverse drug reactions (ADRs) that may include diarrhea, nausea, rash, electrolyte disturbances, as well as pain and inammation at the injection site. ADRs that are uncommon include vomiting, headaches, dizziness, vaginal and oral candidiasis, pseudo­membranous colitis, superinfections, eosinophilia, nephrotoxicity, neutropenia, thrombocytopenia, and fever.
Cephalosporin is a beta-lactam antibiotic that is bactericidal, and, as with other beta-lactam antibiot­ics, it disrupts the synthesis of the peptidoglycan layer that makes up the bacterial cell wall. In order to maintain the structural integrity of the cell wall, the peptidoglycan layer is important. During the process of synthesizing the peptidoglycan, the nal step of transpeptidation is carried out by PBPs. It is known that PBPs bind to the D-Ala-D-Ala at the end of muropeptides (peptidoglycan precursors) in order to cross-link the peptidoglycan. Beta-lactam antibiotics mimic the D-Ala-D-Ala site, thereby irreversibly inhibiting PBP cross-linking of peptidoglycan.
134
There are different ways in which the nucleus of cephalosporin can be modied in order to gain differ­ent properties. Depending on the antimicrobial properties of a cephalosporin, they can be grouped into “generations”. It should be noted that the rst cephalosporins were classied as rst-generation cepha­losporins; however, later, more extended-spectrum cephalosporins were classied as second-generation cephalosporins. It is a well-known fact that each newer generation has greater Gram-negative antimicro­bial properties than the preceding generation, and, in most cases, their activity against Gram-positive organisms has decreased as well. There is, however, a true broad spectrum of activity with the fourth­generation cephalosporins.
The rst generation includes cefalexin, cefadroxil, cefazolin, cefapirin, cefacetrile, cefaloglycin, cefalonium, cefaloridine, cefalotin, cefatrizine, cefazaur, cefazedone, cefradine, cefroxadine, and ceft­ezole (Figure 1.39).
Second generation includes cefuroxime, cefprozil, cefaclor, cefonicid, cefuzonam, cefamandole cefmetazole, cefminox, and cefbuperazone (Figure 1.4 0).
Third generation includes cefdinir, ceftriaxone, ceftazidime, cexime, cefpodoxime, ceftiofur, cefo­taxime, ceftizoxime, cefditoren, ceftibuten, cefovecin, cefdaloxime, cefcapene, cefetamet, cefmenoxime, cefodizime, cefpimizole, cefteram, ceftiolene, cefoperazone, and cefotiam (Figure 1.41). Flomoxef and latamoxef are in a new, related class called oxacephems.
135
Fourth generation includes cefepime, cefquinome, cederocol, cefclidine, ceuprenam, cefoselis, cefozopran, and cefpirome (Figu re 1.42).
Fifth generation includes ceftaroline fosamil, ceftolozane, and ceftobiprole (Figure 1.43).
1.3.3 Cephamycins
There is a group of antibiotics called cephamycins (Figure 1.4 4), which are beta-lactams. As a matter of fact, they are very similar to cephalosporins, and cephamycins are sometimes classied as cephalo­sporins as well. Similarly to cephalosporins, cephamycins are also based upon the cephem nucleus. In contrast to most cephalosporins, cephamycins are very effective against bacteria that live in anaerobic conditions. In the beginning, cephamycins were produced by Streptomyces, but synthetic versions have also been developed.
There is a methoxy group at the position 7-alpha of cephamycins. A further advantage of cephamy­cins is that they are stable against organisms that produce extended-spectrum beta-lactamase (ESBL), although their use in clinical practice for this indication is not yet widespread. One of the most com­monly used cephamycins is cefoxitin, while cefotetan is another (Figure 1.45).
As a second-generation cephamycin antibiotic, cefoxitin was formulated by Merck & Co., Inc. in the year following the discovery of cephamycin C, in 1972, and is derived from cephamycin C. Cefoxitin was synthesized in order to create an antibiotic that has a broader spectrum of activity.
Cefoxitin has demonstrated in vitro antimicrobial activity against a broad range of Gram-positive and Gram-negative bacteria, including anaerobes, in many different experiments. In addition to this, it is inactive against most strains of P. aeruginosa as well as many strains of E. cloacae. In addition, staphylococci that are resistant to methicillin and oxacillin should also be considered clinically resistant to cefoxitin, even if they test susceptible to the drug in vitro. The following are the major bacterial strains
136
29Beta-Lactams
https://t.me/med1917
FIGURE 1.39 First-generation cephalosporin antibiotics: cefalexin, cefadroxil, cefazolin, cefapirin, cefacetrile, cefalo-
glycin, cefalonium, cefaloridine, cefalotin, cefatrizine, cefazaur, cefazedone, cefradine, cefroxadine, and ceftezole.
30 Chemistry and Biology of Beta-Lactams
https://t.me/med1917
FIGURE 1.40 Second-generation cephalosporin antibiotics: cefuroxime, cefprozil, cefaclor, cefonicid, cefuzonam, cefa-
mandole cefmetazole, cefminox, and cefbuperazone.
31Beta-Lactams
https://t.me/med1917
FIGURE 1.41 Third-generation cephalosporin antibiotics: cefdinir, ceftriaxone, ceftazidime, cexime, cefpodoxime,
ceftiofur, cefotaxime, ceftizoxime, cefditoren, ceftibuten, cefovecin, cefdaloxime, cefcapene, cefetamet, cefmenoxime, cefodizime, cefpimizole, cefteram, ceftiolene, cefoperazone, and cefotiam.
that are susceptible to cefoxitin: methicillin-susceptible S. aureus, Streptococcus sp., E. coli, Salmonella sp., P. vulgaris, Flavobacterium sp., and Klebsiella sp.
The most common bacteria resistant to cefoxitin L. monocytogenes, Enterobacter sp., and Bacteroides sp. The following is a list of medically important microorganisms for which susceptibility data have been collected, measured by an MIC, which is an alternative, liquid medium test for susceptibility: E. coli: 0.2–64 μg/mL, H. inuenzae: 0.5–12.5 μg/mL, and S. pneumoniae: 0.2–1 μg/mL.
137
include methicillin-resistant S. aureus, enterococci,